Strategikon Pharma, developer of a novel clinical trial planning, budgeting, outsourcing and vendor management tool, Clinical MaestroTM, has named Farah Ahmad as its new chief commercial officer, it was reported yesterday.
In this role, Farah will be responsible for strategy and implementation for market access and business development. Farah will report directly to founder and CEO, Anca Copaescu.
The company stated that Farah is a strategic and entrepreneurial business development leader with strong experience building successful sales teams, motivating top performers and driving growth in the clinical development segment. She joins Strategikon from Syneos Health, where she held the position of senior vice president, global business development leader for its Early Phase business unit.
Convergent Therapeutics names new chairman of board of directors
Ionis Pharmaceuticals names new executive vice president, chief global product strategy officer
Cardinal Health names new independent director
Micron Biomedical names new scientific advisor to CEO
MedPharm names new executive chairman
Armonica Technologies names new director
Jazz Pharmaceuticals names new executive vice president and chief financial officer
Jazz Pharmaceuticals names new executive vice president and chief financial officer
Ardigen names new chief commercial officer
AbbVie names new chief executive officer
AMO Pharma collaborates with Population Health Research Institute for tideglusib clinical trial